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Abstract
Venezuelan equine encephalitis virus (VEEV) is a New World alphavirus that can cause fatal encephalitis in humans. It remains a naturally
emerging disease as well as a highly developed biological weapon. VEEV is transmitted to humans in nature by mosquito vectors. Little is known
about VEEVentry, especially in mosquito cells. Here, a novel luciferase-based virus entry assay is used to show that the entry of VEEVinto mosquito
cells requires acidification. Furthermore, mosquito homologs of key human proteins (Rab5 and Rab7) involved in endocytosis were isolated and
characterized. Rab5 is found on early endosomes and Rab7 on late endosomes and both are important for VEEVentry in mammalian cells. Each was
shown to have analogous function in mosquito cells to that seen in mammalian cells. The wild-type, dominant negative and constitutively active
mutants were then used to demonstrate that VEEV requires passage through early and late endosomes before infection can take place. This work
indicates that the infection mechanism in mosquitoes and mammals is through a common and ancient evolutionarily conserved pathway.
© 2007 Elsevier Inc. All rights reserved.Keywords: Alphavirus; Virus entry; Endocytosis; Virus infection; Mosquito cell; Rab5; Rab7Introduction
Alphaviruses are classified as either NewWorld or OldWorld
viruses, based on geographic origin. Only the New World
alphaviruses have the ability to cause fatal encephalitis in
humans. Venezuelan equine encephalitis virus (VEEV) is the
most important human pathogen among the New World
alphaviruses and it remains a naturally emerging disease as
well as a highly developed biological weapon (Weaver et al.,
2004). Hundreds of thousands of people have been involved in
sporadic outbreaks of febrile and neurological disease caused by
VEEV since 1938 (Weaver et al., 2004). There is currently no
publicly available vaccine for VEEVand the experimental mili-
tary vaccine has poor efficacy (Russell, 1999). In addition, noAbbreviations: VEEV, Venezuelan equine encephalitis virus; SFV, Semliki
forest virus; SIN, Sindbis virus; VSV, vesicular stomatitis virus; MLV, murine
leukemia virus; WT, wild type; DN, dominant negative; CA, constitutively
active; env, envelope protein.
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doi:10.1016/j.virol.2007.07.012specific antiviral regimens are available for treatment of VEEV
disease and the broad spectrum antiviral Ribavirin is ineffective
(Canonico et al., 1984). To develop successful treatments for
VEEV infection, a better understanding of the pathogenesis of
this virus is necessary.
VEEV particles, like those of other alphaviruses, have icosa-
hedral symmetry and are surrounded by a lipid bilayer.
Embedded in this bilayer are two viral glycoproteins, E1 and
E2. These envelope proteins (envs) are responsible for viral
attachment to a susceptible host cell receptor and fusion with
host cell membranes. After membrane fusion, the viral RNA
core can be released into the cellular cytoplasm (Weaver et al.,
2004). In mammalian cells, alphavirus membrane fusion is
generally thought to be triggered by acidification during endo-
cytic uptake of the virus (Marsh et al., 1984). The mechanism of
entry that a virus uses to gain access to the cell is an important
aspect of pathogenesis but little is known about the VEEVentry
process.
It has been well established that the Old World alphavirus
Semliki Forest Virus (SFV) enters mammalian cells by receptor-
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Sieczkarski and Whittaker, 2003). Upon binding a cellular
receptor, SFV is internalized in clathrin-coated pits then routed
through endosomes along the endocytic trafficking pathway.
Inhibition of endosomal acidification by chemical inhibitors
blocks SFV nucleocapsid release into the cellular cytoplasm
(Helenius et al., 1982). It has been shown that SFV requires a
pH of 6.2 for fusion with a cellular membrane, which likely
occurs in the early endosome (Sieczkarski and Whittaker,
2003). In contrast, work with another Old World alphavirus,
Sindbis virus (SIN), indicated productive infection without the
need for a pH-dependent endocytic pathway (Hernandez et al.,
2001; Paredes et al., 2004). This disparity in entry pathways
seen within OldWorld alphaviruses indicates that multiple entry
pathways may be used and the entry pathway of New World
alphaviruses, such as VEEV, cannot be inferred based on
experiments done with Old World alphaviruses.
VEEV is maintained in nature in a rodent reservoir and is
transmitted to humans by mosquito vectors. Mosquito salivary
glands need to be infected with virus before transmission can
take place (Weaver et al., 2004). As for mammalian cells, little is
known about the pathogenesis of this virus in the mosquito.
Again, there is controversy as to the entry mechanism and
pathway used to infect mosquito cells. It was recently reported
that exposure to low pH was not a requirement for the RNA of
SIN to penetrate into the cytoplasm of mosquito cells
(Hernandez et al., 2001). In this case, it remains unclear if an
endocytic route was followed or not. The entry route followed by
VEEV to infect mosquitoes is also unknown. A thorough
understanding of the virus entry process could lead to new
targets that may help break the human/vector infection cycle.
Recent insights into endosomal trafficking mechanisms have
provided new tools for dissecting entry pathways taken by
natural ligands and pathogens such as viruses. To drive endo-
somalmovement andmaturation, specific proteins are added and
removed on the cytoplasmic face of the vesicle throughout the
trafficking process. The GTPases known as Rab proteins are
known to be crucial for regulating all intracellular membrane
transport activities as well as generating and maintaining
vesicles along the endocytic pathway (Bucci et al., 1992; Zerial
and Stenmark, 1993). Two well-characterized endosomal
proteins that have been used to follow endocytic trafficking as
well as disrupt the endocytic pathway are the small GTPases
Rab5 and Rab7. Rab5 plays a key role in the trafficking of
ligands from the cell surface into the cell via early endosomes.
Rab7 regulates transport from the early endosome to the late
endosome and is involved in the biogenesis of lysosomes (Bucci
et al., 1992, 2000). Consequently, Rab5 is located on early
endosomes and Rab7 can be found on late endosomes.
Dominant-negative mutants of both proteins, as well as a
constitutively active form of Rab5, have been widely used to
inhibit various steps along the endocytic trafficking pathway in
mammalian cells (Galperin and Sorkin, 2003; Li et al., 1994).
These proteins have also been used to inhibit viral infection for
viruses that utilize an endocytic pathway to gain entry into cells.
Rauma et al. showed that adenovirus uptake is increased when
wild-type Rab5 is overexpressed and decreased upon expressionof the dominant-negative form of Rab5 (Rauma et al., 1999).
Many other viruses, including influenza, have been shown to
require both Rab5 and Rab7 for infection using the wild-type
and dominant negative forms of the proteins in mammalian cells
(Sieczkarski andWhittaker, 2002b). In our previous work, it was
shown that in mammalian cells, VEEV requires both Rab5 and
Rab7 for productive entry and infection. This suggests that the
virus needs to travel through both early and late endosomes
before fusion can occur and the viral genome can get released
into the cytoplasm (Kolokoltsov et al., 2006).
It was previously unknown if mosquito cells contain func-
tional Rab5 or Rab7 counterparts to those in mammalian cells.
Furthermore, as indicated above, it is unclear if alphaviruses use
an endocytic pathway to enter and infect mosquito cells or which
proteins may be involved. Recently, the genomes for Aedes
aegypti and Anopheles gambiae mosquitoes were sequenced
and made available (Holt et al., 2002; Kaufman et al., 2002;
Loftus, 2005). Here, we have identified and isolated mosquito
homologs of human Rab5 and Rab7. Both genes share greater
than 80% amino acid identity with those found in mammalian
cells. We characterized each protein and show that they function
analogously to human Rab5 and Rab7. Furthermore, their
dominant-negative (DN) and constitutively active (CA) mutants
give phenotypes similar to the mammalian proteins. Using these,
as well as the human genes, the proteins were expressed in
mosquito cells and their effects on VEEV entry and infection
were studied.We find that VEEVenters mosquito cells through a
pH-dependent endocytic pathway requiring both Rab5 and Rab7
and that acidification of the endosome is required for productive
infection to take place.
Results
VEEV enters and infects cells through a pH-dependent
mechanism
It was previously shown that SFV and VEEV enter mam-
malian cells through a pH-dependent endocytic pathway
(Helenius et al., 1982). However, SIN, another alphavirus, was
shown to infect both mammalian and mosquito cells at neutral
pH (Paredes et al., 2004). It remains unclear why such a
difference exists but could be explained by experimental design
differences or differences in entry mechanism of each alpha-
virus. This led us to first determine if VEEV, a New World
alphavirus, enters mosquito cells via a pH-dependent endocytic
pathway. Monensin, chloroquine and ammonium chloride were
used to treat mosquito cells and then the cells were challenged
with virus. Monensin is a cationic ionophore which binds
potassium ions and uncouples the sodium/potassium gradient
across endosomal membranes. This ion gradient supplies the
energy required to pump protons into the endosomes. Ammo-
nium chloride and chloroquine are primary amines that cross the
endosomal membrane and buffer against acidification.
All experiments were done with C710 Aedes albopictus
mosquito cells since VEEV can infect Aedesmosquitoes (Brault
et al., 2002). SIN83-GFP virus was used for initial infection
studies. This virus is composed of the VEEV structural proteins
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be used at a BSL-2 level. It infects cells identically to VEEV, and
has been characterized elsewhere (Paessler et al., 2003). At 8 h
post-infection, more than 60% of untreated cells became in-
fected. In contrast, none of the drug treated cells were infected
(Fig. 1). Even though a range of drug concentrations was tested,
the block to infection was similar with 1, 5, 10 or 50 μM
monensin, 10, 20 or 30 mM ammonium chloride and 5, 10 or
20 mM chloroquine and is therefore not shown. Similar results
were obtained when the same set of compounds was used on
HEK293 cells. The mammalian vacuolar ATPase inhibitor,
Bafilomycin A1, was also tested but did not inhibit infection on
mosquito cells unless used at levels that were obviously toxic to
the cells. This drug was effective at inhibiting infection in
HEK293 cells, so we must conclude that the mosquito vacuolar
ATPase is resistant to its effects (not shown). These observations
indicated that VEEV requires acidification of endosomes in
order to infect mosquito cells.Fig. 1. Infection of C710 cells and HEK293 cells with SIN83 is inhibited by
lysomotropic agents. (A) Cells were incubated in medium alone (DMEM) or
medium with ammonium chloride (DMEM+NH4Cl) and then SIN83 virus
encoding a GFP reporter gene was added to measure infection. C710 cells (left)
or HEK293 cells (right) were used. Images are a composite of phase contrast and
epifluorescence images. (B) Virus titer for cells treated with each indicated
compound, expressed as a percentage of the titer observed for untreated cells.
Each was used at the following concentrations: 20 mM ammonium chloride,
20 mM chloroquine, 10 μM monensin. C710 cells (open bar) or HEK293 cells
(solid bar) were used. Virus was added at an MOI of 0.5. The average±standard
deviation for a triplicate sample is shown.While VEEV infection was effectively blocked by each of
the agents used, it was unclear which step in infection was
affected. It has been reported that chloroquine, monensin and
ammonium chloride block SFV uncoating and nucleocapsid
release into the cytoplasm in mammalian cells (Helenius et al.,
1982). Studies done with SIN, another Old World alphavirus,
indicated that chloroquine and ammonium chloride instead
inhibited infection of mammalian cells by blocking the
synthesis of viral RNA (Cassell et al., 1984). In another study
using mosquito cells, ammonium chloride also inhibited SIN
RNA synthesis while chloroquine increased infection (Hernan-
dez et al., 2001). However, low pH induces fusion of both SFV
and SIN viruses to membranes and ammonium chloride inhibits
this fusion in mammalian cells (Glomb-Reinmund and Kielian,
1998). To determine if the block in VEEV infection was at the
point of entry rather than at a downstream step, the inhibitors
were tested using an entry assay.
Recently, a new entry assay was developed to monitor
penetration of viruses into the cellular cytoplasm in real time
(Saeed et al., 2006). The entry assay permits blocks at the level of
virus entry to be quantitatively identified with high sensitivity.
The assay utilizes viral pseudotypes that contain a murine
leukemia retroviral (MLV) core and have viral envs on the
surface. A protein expressed from the HIV nef gene is used to
create a nef-luciferase fusion protein that is encapsulated into the
virus particle after transfection and budding of the pseudotype.
This assay measures virus entry by the principle of contents
mixing, directly detecting the release of luciferase that will occur
after fusion of cellular and viral membranes. It overcomes
limitations imposed by infection assays, allowing the functions
of the virus envs for entry to be assessed in live cells without
interference from downstream steps such as replication (Fig. 2).
The entry of VEEV, SFV and VSV env pseudotyped viruses
into C710 mosquito cells was compared using the luciferase
release assay. Plasmids used in the production of these pseudo-
types are shown in Fig. 2A. VEEV and SFV were used to
compare the entry behaviour of New to Old World alphaviruses,
respectively. The VSV pseudotype was included as a positive
control since it is well established that VSVenters cells through a
pH-dependent, clathrin-dependent endosomal route and utilizes
an endocytic pathway in both mammalian and mosquito cells
(Marsh and Helenius, 1989; Matlin et al., 1982; Superti et al.,
1987). Virus titer and luciferase activity for a set of virus
preparations is shown in Table 1. The luciferase activities of each
of the virus pseudotypes varied over a sixfold range. Virus titer
did not correlate well to particle-associated luciferase activity
and is likely due to the observation that similar numbers of MLV
particles bud from cells irrespective of the presence of an env on
their surface (Sharma et al., 1997). However, luciferase activity
on cells showed a closer correlation with virus titer and indicated
that luciferase activity reflected env-dependent entry of virus
into cells.
Since virus entry kinetics in mosquito cells was poorly
understood, a time course of entry was first established. The
pseudotyped viruses were incubated with either HEK293 or
C710 cells and samples were tested for luciferase activity at ten
time points, up to 135 min. The HEK293 cells were incubated at
Table 1















VSV 2.3×108 6490±258 3241±318
VEE 1.5×105 925±84 9.22±0.8
SFV 2.5×106 4144±129 17.39±1.2
10A1 MLV 8.0×106 1021±126 52.21±4.8
a A GFP-encoding MLV pseudotyped virus was used. Virus titer was
determined by limiting dilution and counting colonies of GFP-expressing cells
48 h after addition of virus to HEK293 cells and expressed as colony-forming
units (cfu) per ml.
b Luciferase activity was determined by lysing purified particles in cell lysis
buffer supplied as part of the Steadyglo luciferase assay kit (Promega).
Luciferase assay buffer was added and activity was then measured in a Turner
20/20 luminometer. The average of three measurements±standard deviation is
shown for each viral pseudotype.
c 1 ml of viral supernatant was added to 106 HEK293 cells and the relative
luciferase activity (counts/s) was measured after 1 h of incubation. The average
of three measurements±standard deviation is shown for each viral pseudotype.
Fig. 2. Production of pseudotype viruses for use in luciferase virus entry assay.
(A) 293FT cells were transfected with plasmids encoding the indicated
recombinant genes. The first plasmid codes for viral envelope proteins (VEEV,
SFV, VSVor 10A1MLV were used), the second codes for infection GFP marker
(Ψ-GFP), the third encodes the MLV core structural proteins and polymerase
(gag–pol) and the fourth for the nef-luciferase fusion protein. After 48 h, virus
containing encapsulated luciferase was collected, purified and used for virus
entry assays. (B) Schematic representation of the luciferase-based virus entry
assay. Virus entry occurs after fusion of virus and cell membranes. Luciferase
encapsulated inside the virus particle (star) is then released into the cell cytoplasm
through contents mixing. The release is measured by perfusing the cell with
luciferin, the substrate for luciferase which enters through high activity cell
membrane permeases (Craig et al., 1991). Emitted light is then measured.
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are the optimal growth temperatures for mammalian and insect
cells, respectively. At 75 min, the entry signal for the VEEV
pseudotype peaked in both C710 and HEK293 cells. The signal
for the VSV pseudotype entry peaked later at 105 min in both
cell types. In HEK293 cells, the SFV pseudotype entry signal
peaked at 105 min while in C710 cells the signal peaked earlier,
at approximately 90 min (Fig. 3). Based on these findings, an
incubation time of 60 min was used for the remaining entry
studies. The decrease in signal following the plateau was likely
the product of luciferase degradation in the cells (T1/2 of
luciferase is 30 min in mammalian cells).
To determine the effects of inhibiting endosomal acidification
on virus entry, C710 cells were pre-incubated with monensin,
chloroquine and ammonium chloride at the same concentrations
used for infection studies for 1 h at 27 °C (1, 5, 10 and 50 μM
monensin, 10, 20 and 30 mM ammonium chloride and 5, 10 and20 mM chloroquine). The luciferase-containing virus particles
were then added to the cells for an hour and entry signals were
determined via measurement of luciferase activity. Each of the
chemical inhibitors reduced the entry signal to a similar low level
for the viral pseudotypes used and the effect of a middle dose is
shown (Fig. 4). VSV and VEEV signals were completely
abolished. This is similar to the pattern seen with VSV and
VEEV in previous work using mammalian cells (Kolokoltsov et
al., 2006). Low levels were still detected in the presence of the
inhibitors for the SFV pseudotype (Fig. 4, lower panel), with a
small portion of the virus fusion from untreated cells remaining
in the presence of each inhibitor. This suggested that SFVentry
pathway or mechanism may differ from VEEV but will need a
more detailed analysis to be confirmed. A pseudotype was also
made bearing the envs of the 10A1 strain of MLV, which is
known to enter cells at the cell surface through a pH-independent
mechanism (Blanchard et al., 2006), and was used in the entry
assay as a control for both cell viability and assay function. The
10A1 MLV pseudotype efficiently entered the C710 cells in the
presence of all three inhibitors (Fig. 4) and indicated that cells
were competent for virus infection and that the assay was
unaffected by each chemical treatment. These findings indicated
that the inhibitors block VEEV infection by acting at the level of
virus entry and that acidification, likely in an endocytic
compartment is required to allow VEEV entry to occur in a
mosquito cell.
Identification of Rab5 and Rab7 in mosquito cells
Having established that VEEV uses a pH-dependent route to
enter mosquito cells, we then wanted to identify if an endocytic
pathway was involved. Recently it was shown that VEEV needs
both functional Rab5 and Rab7 endosomal GTPases for entry in
mammalian cells (Kolokoltsov et al., 2006). Rab5 is found on
early endosomes and Rab7 is found on late endosomes. Both are
Fig. 4. Lysomotropic agents prevent alphavirus entry into mosquito cells. C710
cells were incubated for 1 h at 27 °C with each of the indicated agents. Each
inhibitor was used at the following concentrations: 20 mM ammonium chloride,
20 mM chloroquine and 10 μM monensin. Entry was then measured using the
luciferase entry assay with pseudotypes bearing the envs of VEEV, SFV, VSV
and 10A1MLVas indicated. Entry was measured at 1 h after addition of virus to
cells. Average luciferase activity (log percent of control) is shown for assays
performed in triplicate±standard deviation.
Fig. 3. Kinetics of pseudotyped virus entry. HEK293 cells (top panel) or C710
cells (bottom panel) were incubated with viral pseudotypes bearing the envs of
VEEV (circles), VSV (squares) or SFV (triangles). Excess virus was washed
free of cells. At the times indicated, entry was measured and was expressed as a
percentage of the maximum signal obtained for each viral pseudotype. Entry
was measured at ten time points, from time 0 to 135 min. Assay was done in
duplicate and the average±standard deviation was plotted. The effective MOI
for this experiment was determined to be 0.1 by measuring virus infection by
GFP infection marker expression as described in Materials and methods.
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et al., 1992, 1995, 2000; Feng et al., 1995, 2001). If VEEV
follows a similar pathway in mosquito cells as in mammalian
cells, then entry and infection should have a similar dependence
on mosquito homologs of these proteins. The genome of A.
gambiae was recently sequenced and published and the
sequencing of the A. aegypti genome is near completion (Holt
et al., 2002; Kaufman et al., 2002; Loftus, 2005). By sequence
comparison, mosquito protein homologs were identified that
showed 82% and 88% amino acid identity to human Rab5 and
Rab7 genes, respectively. The aligned mosquito sequences had
E values of b1e−83 for human Rab7 and 2e−69 for human
Rab5. Since the E value represents the chance of obtaining a
similar alignment strictly by chance these low E values indicated
that the genes identified were highly likely to be related genes
and possibly functional homologs. Interestingly, the human
genome contains three Rab5 isoforms (Bucci et al., 1995) but
only one mosquito equivalent was identified within each se-
quence database. Both humans and mosquitoes appear to only
have one form of the Rab7 protein.
cDNA-encoding-related Rab5 and Rab7 mosquito genes
were isolated from A. gambiae and A. albopictus cDNA
libraries, respectively. The sequences of the isolated DNA
matched those identified in the databases except for severalsilent mutations and have been submitted to GenBank (NCBI)
with accession numbers: A. albopictus Rab7 – 858647 and
A. gambiae Rab5 – 863568. Alignments to human and Droso-
phila homolog amino acid sequences are shown in Fig. 5. Each
was inserted into an insect expression plasmid, pAc5.1/V5-HisA
(Invitrogen, CA), as a fusion to GFP (GFP tag was placed at the
N-terminus of each protein). The human Rab5 and Rab7 genes,
each similarly tagged with GFP, were also cloned into the same
mosquito expression construct for comparison with the mos-
Fig. 5. Amino acid alignment of human and mosquito Rab5 and Rab7 proteins. Amino acid alignment of the three isoforms of the human (H. sap.) Rab5 GTPase, the
Drosophila melanogaster (D. mel.) Rab5 and an Aedes aegypti mosquito homolog (A. aeg.) isolated from a cDNA library. Sequences were aligned using ClustalW
(Thompson et al., 1994) and regions of homology shaded using Boxshade software. The GTP-binding domains are indicated by horizontal bars (GTP-BD) and the
amino acid substitutions used to create the DN (S34N) and CA (Q79L) forms of Rab5 and DN Rab7 (T22N) are indicated by vertical arrows. The conserved
prenylation domain is also indicated.
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cells and expression was observed after 24 h. Typically, than
2–5% of the cells expressed detectable fluorescent protein.
To confirm that mosquito Rab5 and Rab7 genes were func-
tionally homologous to their mammalian counterparts in endo-
some formation and maturation, amino acid substitutions atconserved residues were made in both proteins that give well
characterized dominant negative (DN) and constitutively active
(CA) phenotypes in the corresponding mammalian proteins
(Bucci et al., 2000; Feng et al., 1995; Stenmark et al., 1994). The
location of these mutations is shown within the alignments in
Fig. 5. To characterize the function of each protein bearing these
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transfected into mosquito cells and those coding for human
proteins were transfected into human cells. The cells were
examined by confocal microscopy to compare expression and
localization within the cell.
The Rab5 wild type (WT) protein from both humans and
mosquitoes shared a similar expression pattern in human (HeLa)
and mosquito (C710) cells, respectively. Each protein was
visible as punctate, vesicular staining within the cellular cyto-
plasm (Figs. 6A and B). Similarly, both the human and mosquitoFig. 6. Characterization of mosquito homologs of human Rab5 and Rab7. All cells we
shown. Pictures are of middle cell slice clearly showing cytoplasm vs. membrane.
transfected with expression plasmids encoding either GFP alone or Rab5 WT, Rab5
GFP. (A) Putative mosquito homologs of Rab5 genes and those carrying amino acid s
and (B) human homologswere transfected into HeLa cells. Cells were then incubatedw
(HeLa cells) and cells were then imaged. For Rab5Q79L in C710 cells, DAPI counter
expression plasmids encoding the mosquito homolog of Rab7WT fused to GFP. Cells
by microscopy.WT Rab7 proteins expressed equally well in human and mos-
quito cells and gave similar staining, though less punctate and
more diffuse than the Rab5 expression. The mutant forms of
both human and mosquito Rab5 and Rab7 also expressed well in
the mosquito cells and gave similar phenotypes as in the
mammalian cells. In each case the pattern of expression of the
human protein matched that previously described and the mos-
quito proteins gave similar expression patterns. This indicated
that each protein likely served similar roles in endosome bio-
genesis and function in both human and mosquito cells.re fixed and observed by confocal microscopy. Individual representative cells are
All experiments were repeated three times with similar outcomes. Cells were
Q79L (constitutively active) or Rab5 S34N (dominant negative) genes fused to
ubstitutions making DN or CA forms were transfected into C710 mosquito cells
ith Alexa Flour 594-labelled transferrin for 30min at 27 °C (C710 cells) or 37 °C
stain was used to outline cell nucleus. (C) C710 cells were transfected with insect
were incubated with LysoTracker Red for 1 h at 27 °C and then cells were imaged
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proteins on function
To further examine if the mosquito Rab5 and Rab7 genes
made protein with similar function to their human counterparts,
transfected cells were then incubated with labelled human trans-
ferrin. Transferrin uptake in mammalian cells occurs primarily
through clathrin-mediated endocytosis and disruption of this
pathway results in accumulation of transferrin prior to the block
(Damke et al., 2001; van Dam and Stoorvogel, 2002). Human
transferrin has been successfully used in Drosophila cells for
study of endocytosis (Blitzer and Nusse, 2006) but it was
unknown if it would function in mosquito cells. Human trans-
ferrin was incubated with the mosquito cells and then the cells
were fixed and stained with antibody against cytoplasmic tail of
the human transferrin receptor (this domain is highly conserved
across many species including mosquitoes). Co-localization of
transferrin and antibody staining confirmed that the mosquito
transferrin receptor was involved in the endocytic uptake of the
human transferrin protein (Fig. 7).
Since Rab5 controls early endosome formation, disrupting
Rab5 function in mammalian cells results in inhibition of rapid
transferrin uptake and sequestration of transferrin close to the
cell surface (Bucci et al., 1995; Stenmark et al., 1994; Trischler
et al., 1999). Similarly, in mosquito cells, transferrin uptake was
rapid and evident at 15 min after the addition of labelled
transferrin, consistent with the rapid endocytic uptake seen in
mammalian cells. Confocal microscopy revealed similar
patterns of staining for transferrin in the human Rab5 WT-
expressing HeLa cells and in the mosquito Rab5WT-expressing
C710 cells with transferrin often associated with Rab5-contain-Fig. 7. Human transferrin colocalizes with mosquito transferrin receptor in C710
cells. To verify that fluorescently labelled human transferrin binds to the
mosquito transferrin receptor, live cells were incubated at 27 °C with Alexa
Flour 594-labeled human transferrin (red) for 30 min and then fixed in
paraformaldehyde. Cells were then stained with antiserum raised against a
conserved cytoplasmic-domain peptide of the transferrin receptor (green). The
image is a single optical slice taken through the center of the cell by confocal
microscopy. Arrowheads indicate transferrin staining that is co-localized
(orange) or adjacent to transferrin receptor staining in one representative cell.ing vesicles (Figs. 6A and B). The activity of the Rab5 DN
mutant (S34N) was also determined by transferrin uptake. The
expression of both human and mosquito DN Rab5 gave diffuse
staining in the cell cytoplasm with punctate, vesicular staining
along the cell membrane. This expression blocked transferrin
internalization into both cell types, with the transferrin re-
maining at the cell surface in small vesicles and possibly coated
pits. This is consistent with the function of Rab5 in early endo-
some formation and trafficking (Figs. 6A andB). The human and
mosquito CA Rab5 (Q79L) was present on large fluorescent
vesicles that contained transferrin (Figs. 6A and B). This is
consistent with the CA form of Rab5 causing accumulation of
early endosomes by preventing fusion of early with late endo-
somes and inhibiting the maturation of endosomes beyond the
early endosome. In each case, the mosquito gene functioned
equivalently to the human gene indicating that the mosquito
Rab5 homolog is similar to that found in human and other
mammalian cells. The pattern of transferrin uptake and the
phenotypes of each mutant appeared consistent with a conserved
role in insect cell endosome formation and maturation.
The function of the Rab7 mosquito homolog was then tested.
Transferrin is recycled back to the cell surface from the early
endosome and therefore its pathway should be unaffected by the
DN Rab7 mutant, since it is located on and influences late
endosomes. Indeed, expression of both WT Rab7 and DN Rab7
(T22N) allowed transferrin uptake into the mosquito cells. Rab7
has been reported as important in late endosome formation and
lysosome biogenesis (Bucci et al., 2000; Feng et al., 1995). To
assess if Rab7 associates with vesicles in mosquito cells,
markers for late endosomes and lysosomes must be identified in
mosquitoes. Mammalian antibodies recognizing late endosome
and lysosome markers have yet to be made for insect cells.
Instead, the cells were transfected with WT Rab7 and then
incubated with Lyso Tracker (Invitrogen, CA). This weak base
accumulates and reaches peak fluorescence in highly acidic
compartments, typically late endosomes and lysosomes and has
previously been used to characterize Rab7 function in mamma-
lian cells (Bucci et al., 2000; Gutierrez et al., 2004). It was
observed that cells expressing WT Rab7 accumulated Lyso
Tracker in perinuclear vesicles and that the Rab7 co-localized
with the Lyso Tracker (Fig. 6C). Together with the lack of
association between labelled Rab7 with transferrin, the co-
localization with Lyso Tracker indicated that the Rab7 homolog
was present in late endocytic vesicles and/or lysosomes as
expected. In summary, this portion of the work indicates that
mosquito Rab5 is necessary for early endosome formation and
Rab7 likely has a role in endocytic trafficking towards lyso-
somes. These observations indicate that Rab5 and Rab7 have
conserved roles for endosome function and maturation in insect
cells as in mammalian cells and will be useful for study of virus
entry pathways.
Functional Rab5 and Rab7 are necessary for VEEV infection of
mosquito cells
Given the important roles of Rab5 and Rab7 in endosome
trafficking, it was expected that expression of the DN and CA
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endocytosis was required for infection. Rab5 function will be
crucial if VEEVenters the cell and utilizes early endosomes for
trafficking from the membrane. Rab7 function will be important
if the late endosome must be accessed by the virus before fusion
can occur and the genome can be released. Flow cytometry was
used to get a quantitative and accurate measurement of how
expression of each protein affected subsequent infection of the
mosquito cells by VEEV. After transfection of the plasmids
encoding for the Rab proteins, cells were infected with SIN83.
Cells were analyzed by flow cytometry to detect expression of
GFP–Rab5/Rab7 fusion proteins and subsequent infection with
the SIN83 virus. Infection of cells expressing the indicated
protein was compared to infection of cells expressing the
transfected gene fused to GFP. Controls were virus alone,
expression of GFP alone and virus infection of cells expressing
GFP alone. Flow cytometry allowed a detailed analysis of the
affects of expressing each of the recombinant Rab genes on
virus infection and gave internal controls for variation in cell
number, MOI and transfection efficiency. The raw flow
cytometry data is shown in Fig. 8.
First, the mosquito cells were transfected with human Rab5
and Rab7 genes and the effect expression on virus infection was
measured in mosquito cells. The wild-type human Rab5 had
little effect on infection but both the DN (S34N) and the CA
(Q79L) forms of human Rab5 significantly decreased the SIN83
infection (Fig. 9, upper panel) by 45% and 30%, respectively
(Pb0.01). Next, the mosquito genes were tested. Interestingly,
as the amount of mosquito Rab5 WT homolog expression in-Fig. 8. FACS analysis of infection in mosquito cells expressing wild type and DN or C
each indicated gene fused to GFP. After 1 day, cells were infected with SIN83 virus.
and divided into 4 quadrants (gates a, b, c, and d, shown top left panel) where a=cells
expressing the GFP fusion protein, c=cells infected and expressing the GFP fusion pr
fusion protein. The impact of gene expression on infection was calculated as shown
protein is expressed as a percentage of uninfected cells expressing the GFP-tagged
infectivity, expression plasmid transfection efficiency and total cell number. The top
added virus) and virus infection in the presence of GFP. The lighter shades indicatecreased, the infection by SIN83 also increased, rising 2.5-fold
over the infection seen for cells transfected with only GFP. This
suggested that Rab5 activity in mosquito cells is normally
limiting for infection. Similar to the human Rab forms, the
expression of the mosquito Rab5 DN (S34N) and CA (Q79L)
proteins also decreased infection but to a greater extent, by an
average of 53% and 57%, respectively (Pb0.01) (Fig. 9, middle
panel). Neither the human nor the mosquito Rab5 S34N protein
expression and subsequent infection with SIN83 differed
significantly from the Rab5 Q79L protein expression and
infection (PN0.05). The results of the flow cytometry assay
clearly illustrated that Rab5 function and therefore early
endosomes are necessary for mosquito cell infection with the
SIN83 virus. The experiment was repeated with WT and DN
(T22N) mosquito Rab7 proteins. The transfection of the WT
Rab7 did not have a significant impact on SIN83 infection,
instead increasing infection by a small amount (20%). In
contrast, expression of the DN Rab7 mutant (T22N) signifi-
cantly lowered the infection of the cells (Fig. 9, lower panel), by
45% (Pb0.05). Together, these results suggest that functional
early as well as late endosomes are important for VEEVinfection
of mosquito cells. We conclude that VEEV has a distinct
requirement for endosomal acidification and endosomal traf-
ficking in mosquito cells.
Discussion
Many families of viruses enter host cells through an endo-
cytic pathway rather than through the cell surface. Endocytosis isA forms of mosquito Rab5 and Rab7 proteins. C710 cells were transfected with
Cells were then stained for VEEV env expression. Cells were analyzed by FACS
infected but not expressing the GFP-fusion protein, b=cells not infected and not
otein at moderate to high levels and d=cells not infected but expressing the GFP
at lower right where the proportion of infected cells expressing the GFP fusion
protein. This analysis internally controls for experimental variation in: virus
three panels serve as controls showing staining with virus alone, GFP alone (no
higher numbers of cells.
Fig. 9. Rab5 and Rab7 are necessary for infection of mosquito cells with SIN83.
C710 cells were transfected with an insect expression plasmid containing either
GFP alone or genes for either the human or mosquito proteins Rab5 WT, DN
Rab5 (S34N), CA Rab5 (Q79L), Rab7 WT, DN Rab7 (T22N) fused to GFP.
After 24 h, cells were challenged with SIN83 virus. Cells were fixed 12 h post-
infection and stained with an anti-VEEVenv antibody, as a marker of infection.
FACS analysis was used to determine the impact of gene expression on infection
and infection efficiency was calculated as described in Fig. 8. The effects of
both human Rab5 expression (upper), mosquito Rab5 homolog expression
(middle) and mosquito Rab7 homolog expression (bottom) are shown. The
average of three separate experiments is shown±standard deviation. *Pb0.05,
**Pb0.01.
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enveloped viruses which require low pH-induced fusion to occur
between the viral and cellular membranes in order to release the
viral genome (Marsh and Helenius, 2006; Sieczkarski and
Whittaker, 2002a).West Nile, Vesicular Stomatitis and Influenza
A viruses require a functioning endocytic pathway in order to
enter and infect cells and disabling steps along this pathway
causes a marked reduction in virus entry (Chu and Ng, 2004;
Sieczkarski and Whittaker, 2002a). Most of the information on
alphavirus attachment and entry into host cells has come from
work with Old World alphaviruses such as SFV and SIN in
mammalian cell types. Little is known about the infection path-way taken by New World alphaviruses in mammalian cells and
especially into the cells of their vector, mosquitoes.
By using a real-time contents mixing assay to measure VEEV
entry, we first established that for contents mixing to take place,
acidification was needed. This assay can be used with any
pseudotyped virus and can precisely detect entry by measuring
the fusion of the viral membrane with the cellular membrane and
release of virion contents. We show for the first time that this
assay can be effectively used in mosquito cells to gain insight
into virus entry in a non-mammalian host. Both the New World
VEEV and Old world SFV had similar requirements with entry
being impaired by all lysosomotropic agents tested except
Bafilomycin. Bafilomycin was not effective at concentrations
that block entry in mammalian cells. At higher doses, significant
toxicity was observed in mosquito cells and the control virus
used, 10A1 MLV, which enters cells through a pH-independent
pathway (Blanchard et al., 2006) was also affected. We suspect
that the mosquito vacuolar ATPase is resistant to the actions of
this drug. However, overall, we conclude that acidification is a
requirement of virus entry into Aedes mosquito cells.
In mammalian cells, endocytic vesicle trafficking and fusion
is partly controlled by small GTPases known as Rab proteins.
Rab5 is responsible for early endosome function and regulation,
while Rab7 is responsible for the maturation and regulation of
late endosomes (Sieczkarski and Whittaker, 2003). There has
been a great deal of research on these proteins in mammalian
cells and this has led to a greater understanding of the endocytic
mechanisms of the cell. Several Rab proteins have been
identified in the fruit fly Drosophila, and have been shown to
be important in endocytosis (Guha et al., 2003; Satoh et al.,
1997a,b; Wucherpfennig et al., 2003) but prior to the current
work nothing was known about such proteins in the mosquito.
Our results demonstrate for the first time that mosquitoes have
counterparts to the mammalian proteins that are essential for the
functioning of the endocytic pathway.
By expressing the wild type, DN or CA forms of Rab5 and
Rab7 mosquito proteins in mosquito cells, we demonstrated that
the mosquito cell also utilizes these proteins for endocytosis
much like the mammalian cell does. Each appears to be a true
functional homolog of its mammalian counterpart. Protein
distribution and ligand uptake are similar. The effects of making
amino acid substitutions in the conserved GTP-binding domains
also give similar outcomes. The DN form of mosquito Rab5
prevented the transferrin uptake while the DN form of Rab7
affected lysosome biogenesis as in mammalian cells (Li et al.,
1994). The CA Rab5 protein formed the classical large vesicles
that accumulated transferrin in the mosquito cell as seen for the
mammalian counterpart. Our results indicate that Rab5 and Rab7
have an evolutionary conserved role in endosome biogenesis
that is shared between mosquitoes and humans.
Both Rab5 and Rab7 proteins have been shown to be
important for entry and infection for several viruses. Entry of
influenza virus requires functional Rab5 as well as Rab7, while
SFVand VSVonly need functional Rab5 present for productive
infection (Sieczkarski and Whittaker, 2003). SFV was shown to
require Rab7 function in mammalian cells in order to reach the
late endosome but it is unclear if access to this compartment
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Vonderheit and Helenius, 2005). In mammalian cells, VEEV
infection was shown to require both Rab5 and Rab7, indicating
that the virus must access both early and late endosomes for
productive infection (Kolokoltsov et al., 2006). In addition to
regulating endocytosis, Rab5 and Rab7 may act as signalling
molecules to create the appropriate environment in the mosquito
cell for virus entry and infection. Here, disruption of the endo-
cytic pathway by expression of DN and CA forms of Rab5 and
Rab7 demonstrated the importance of this pathway for VEEV
infection of mosquito cells. The expression of the wild type
form of the mosquito Rab5 homolog increased infection with
VEEV (SIN83) virus showing that early endosome formation
may be limiting for infection. In contrast, the DN and CA form
greatly and significantly reduced mosquito cell infection.
Similarly, DN Rab7 expression decreased infection with
VEEV. We conclude that functional Rab5 and Rab7 are
required for VEEV entry into mosquito cells indicating a need
to access a late endosome after the early endosome in order to
establish an infection.
There are many proteins involved in the mammalian
endocytic pathway, which most likely have homologs within
the mosquito genome. The recent sequencing of both the A.
gambiae and A. aegypti mosquito genomes provides a novel
opportunity to find these genes and determine how they function
in the mosquito endocytic pathway as well as what their roles
may be in virus entry and infection. Many viruses that are highly
infectious and sometimes fatal to humans are transmitted by
mosquitoes or other insect vectors. Knowledge of the molecular
mechanisms of the endocytic pathway in mosquito and other
insect cells could greatly improve our abilities to break the
human-vector infection studies in highly pathogenic arbo-
viruses. This research represents the first identification and
characterization of mosquito endocytic proteins and, impor-
tantly, the involvement of these proteins in virus entry. Mosquito
Rab5 and Rab7 are most likely involved in the entry of other
alphaviruses and they may prove useful in investigating
arbovirus entry as well as developing strategies to prevent
arbovirus infection of mosquitoes.
Materials and methods
Chemicals
Chloroquine and monensin were from Calbiochem (San
Diego, CA). Ammonium chloride was from Sigma (St. Louis,
MO).
Cell lines and cultivation
C710 Aedes cells (kindly provided by Dr. Ilya Frolov,
UTMB, TX) were used for entry assays as well as transfection/
infection studies. The cells were grown in DMEM supplemented
with 10% heat-inactivated fetal bovine serum (Gemini Biopro-
ducts, CA), 1% penicillin–streptomycin and 1% tryptose
phosphate broth (Sigma, MO). 293FT cells (Invitrogen, CA)
were used to generate envelope pseudotyped virions and weregrown in the same medium with 0.5 mg/ml of Geneticin
(Invitrogen, CA).
Expression plasmid constructs
All plasmids were prepared using Qiagen kits (Valencia, CA).
A pcDNA3 (Invitrogen, CA) expression plasmid containing the
VEEVenvs from E3 to E1 from subtype IC strain 3908 was used
to make VEEV env pseudotypes (Kolokoltsov et al., 2005).
Similarly, a pcDNA3 expression plasmid containing the SFV
envs was used for SFV pseudotype production and was provided
by Dr. D. Sanders (Indiana University Medical School, IN) and
is described elsewhere (Kahl et al., 2004). For production of the
MLV pseudotype, p10A1 (Clonetech, CA) was used in the
transfection. A plasmid encoding VSV-G (pVSV-G, BD
Biosciences, CA) was used to make vesicular stomatitis virus
(VSV) pseudotypes as described previously (Kolokoltsov et al.,
2005). pGAG-POL, which encodes the murine leukemia virus
(MLV) gag and polymerase, was a gift of Dr. J. Cunningham
(Harvard Medical School, MA). The marker gene encoding
plasmid was based on pFB (Stratagene, CA) and encodes
enhanced green fluorescent protein (GFP) under control of the
MLV LTR and virus packaging sequence (pFB-GFP).
Production of env pseudotyped MLV
MLV particles bearing the envs of VEEV, VSVand SFVwere
made according to previous work (Kolokoltsov et al., 2005).
Briefly, 293FT cells (Invitrogen) were transiently transfected
using calcium phosphate (Chen and Okayama, 1987) with
pGAG-POL, pFB-GFP and plasmids encoding appropriate
envs. The VSV-G-encoding plasmid was used at 1 μg per
transfection and other plasmids were used at 5 μg each. After
overnight incubation, the medium was replaced. When virus
production peaked after a total of 48 h, the supernatants were
collected and filtered through a 0.45-μm cellulose acetate filter.
The filtrate was used directly, or else virus was purified by
pelleting through 20% (w/v) sucrose in 20 mM Tris–HCl,
pH 7.4. Titer of the MLV pseudotypes was determined by
limiting dilution on HEK293 cells and by counting the number
of GFP positive colonies 2 days post-infection.
Luciferase-based entry assay
The rapid entry assay requires that luciferase enzyme is
enclosed within an intact viral envelope. This was achieved by
fusing the luciferase protein to the HIV nef protein. The nef-
luciferase encoding plasmid (pcDNA3-Nef-luc) used in making
virus for entry assays was made by amplifying the nef gene and
cloning it into the pcDNA3 vector that contained the firefly
luciferase gene. This plasmid is described elsewhere (Saeed et
al., 2006). After transient transfection of plasmids encoding viral
structural proteins and the nef-luciferase fusion construct (1 μg),
virions budding from the cell surface incorporate the nef protein
inside the viral envelope. Previously, this method was used
exclusively for mammalian cells but here we show it can be
applied to mosquito cells as well. Entry assays were performed
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natant with 105 cells for 1 h at room temperature at an MOI of
b1. Cells were then pelleted, washed with PBS and lysed by
freeze/thaw to ensure that luciferin could permeate subcellular
compartments. This treatment does not disrupt virus particles yet
ensures that luciferase inside the cell can be accessed by the
luciferin in the buffer. The thawed cells were then resuspended in
Steady-glo luciferase assay buffer (Promega, #E2510) and light
emitted by luciferase was detected after 12 sec using a
luminometer (Turner Biosystems model 20/20).
Use of inhibitors of endosomal acidification
Ammonium chloride and chloroquine were dissolved directly
in DMEM.Monensin was made as a 50mM stock in ethanol. All
were diluted to the concentrations indicated in DMEM imme-
diately before use. For entry assays, cells were pre-incubated
with drug for 1 h at room temperature and then virus was added
as described above.
Use of human endocytic trafficking proteins to identify entry
pathway of viruses
Rab5 is required for early endosome formation and function,
and Rab7 is necessary for late endosome maturation. A
dominant-negative (DN) recombinant form of Rab5, S34N,
blocks early endosome formation in mammalian cells. The
constitutively active (CA) mutant, Q79L, of Rab5 prevents
endosome fusion and results in accumulation of early endo-
somes. Both Rab5 S34N and Q79L encoding plasmids were
provided by Dr. P. Stahl at Washington University Medical
School. Rab7 is required for formation of late endosomes and
expression of the mutant form, T22N (Dr. Wandinger-Ness,
UNM) blocks this step and prevents lysosome biogenesis (Bucci
et al., 2000; Feng et al., 2001). Each protein, when fused to the
C-terminus of GFP, retains its function and permits detection by
fluorescent microscopy and by flow cytometry. For expression
in insect cells, human Rab5 and Rab7 genes similarly fused to
GFP were cloned into an insect expression vector pAc5.1/V5-
HisA (Invitrogen, CA). This vector contains the insect actin 5C
promoter which allows for gene expression in mosquito as well
as mammalian cells (Zhao and Eggleston, 1999).
Identification and use of mosquito homologs to human Rab5
and Rab7
Mosquito homologs of human Rab5 and Rab7 genes were
identified using sequence alignment within the recently pub-
lished A. aegypti and A. gambiae genome sequences using the
human genes as a template. The human amino acid sequences
were aligned against all mosquito genome open reading frames
(ORFs) using TBLASTN (Altschul et al., 1997) and putative
mosquito gene sequences were returned. Exons were identified
within these ORFs and deduced amino acid sequences were then
aligned back to the human amino acid sequences. The mosquito
amino acid sequences had over 80% similarity to the human
genes. This level of similarity suggested the potential foranalogous protein function between the two species. RNA
was extracted from C710 mosquito cells using RNAqueous
(Ambion, TX) and cDNA made by reverse transcription with a
Superscript kit (Invitrogen, CA) according to the manufacturer's
directions. For expression of insect genes, the pAc5.1/V5-HisA
insect expression plasmid (Invitrogen, CA) was modified by
insertion of the GFP coding sequence (pAc5.1-GFP). Rab5 and
Rab7mosquito genes were amplified from the cDNA library by
PCR and cloned into the pAc5.1-GFP vector. The GFP was
placed in-frame and 5′ to the Rab encoding region. PCR oligos
















Restriction endonuclease sites used for cloning are under-
lined. The DN or CA mutant forms of the mosquito genes were
made by making amino acid substitutions at conserved residues
important for GDP/GTP exchange previously characterized in
mammalian homologs, i.e. Rab5 S34N and Q79L and Rab7
T22N. The site-directed mutagenesis was performed at the Re-
combinant DNA Core Facility at UTMB and changes confirmed
by DNA sequencing.
Transfection of plasmids into mosquito cells
The pAc5.1-GFP plasmid containing either the human or
mosquito genes were transfected into C710 cells using Effectene
(Qiagen, CA) according to manufacturer's instructions. Briefly,
for a 10 cm2 plate, 4 μg of DNAwas mixed with 500 μl buffer
EC and 32 μl enhancer was added. This was allowed to incubate
for 5 min on the benchtop. Then 30 μl Effectene reagent was
added and the solution vortexed briefly. After 10 min of
incubation, the solution was added to the cells. Expression was
observed after 24 h and peaked at 48 h.
Transferrin and antibody staining
Alexa Flour 594-labeled human transferrin (Invitrogen, CA)
was added to DMEM (without serum) at a 1:200 dilution and
incubated with cells for 30 min at 27 °C. The cells were then
pelleted, washed with PBS and fixed in 2% paraformaldehyde
before imaging by microscopy. For antibody staining, cells were
fixed in paraformaldehyde and incubated with 1% BSA to block
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incubated with primary antibody diluted as indicated in 1%BSA
in PBS for 1 h. Excess antibody was removed by 3 washes with
PBS and the cells were incubated with secondary antibody,
labelled with the indicated fluorescent dye. Excess was washed
off and the cells were imaged by microscopy.
Infection with SIN83
When studying infection, SIN83, a virus comprising the
structural proteins of VEEV but containing a SIN genome, was
used as described elsewhere (Paessler et al., 2003). It is
antigenically and structurally identical to VEEV but can be
safely used at BSL-2. This virus has the receptor specificity and
entry mechanism of VEEV dictated by the VEEV envs. It was
used as a safe alternative to wild-type VEEV, which is a BSL-3-
restricted virus and select agent. SIN83 was used in flow
cytometry and microscopy experiments and was a gift of Dr. Ilya
Frolov (UTMB, Galveston, TX). Another form of the virus,
SIN83-GFP, had GFP as an infection marker under control of a
second subgenomic 26S promoter and was used where
indicated. Virus titer was determined by plaque formation and
GFP expression, respectively.
Infection analysis by flow cytometry
Insect expression vectors encoding either the human or
mosquito genes were transfected into C710 cells using Effectene
according to manufacturer's instructions. Plasmids were used at
4 μg DNA per 106 cells. After 1 day, cells were infected with
SIN83 virus at an MOI of 1. At 12 h post-infection when viral
proteins were expressed in cells, the cells were removed, pelleted
at 350×g, washed with PBS, pelleted again and fixed in 2%
paraformaldehyde for 10 min at room temperature. The cells
were washed and resuspended in PBS containing 5%BSA. Cells
were then incubated with polyclonal serum raised against VEEV
(ATCC #VR-1250AF) for 20 min at room temperature. Cells
were again pelleted, washed, and incubated for 20 min with a
secondary antibody labelled with Alexa Fluor 647 (Invitrogen,
CA). Cells were analyzed using a Becton-Dickinson FACS-
Canto instrument in the Flow Cytometry Core Facility at
UTMB.
Statistics
Statistics were performed using Graphpad software (Graph-
Pad Prism version 4.00 for Windows, GraphPad Software, San
Diego California USA, www.graphpad.com). Data were com-
pared by one-way ANOVA and analysis included Tukey–
Kramer's post test.
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